Healthpeak Properties (NYSE:DOC) Price Target Raised to $22.00

Healthpeak Properties (NYSE:DOC) had its price target hoisted by UBS Group from $20.00 to $22.00 in a research report released on Wednesday,Benzinga reports. UBS Group currently has a neutral rating on the real estate investment trust’s stock.

DOC has been the topic of a number of other reports. Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday, November 7th. Royal Bank Of Canada raised their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Barclays reduced their price objective on shares of Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 13th. Jefferies Financial Group started coverage on Healthpeak Properties in a research note on Tuesday, September 15th. They set a “hold” rating and a $21.00 target price for the company. Finally, Citigroup lifted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $21.60.

Healthpeak Properties Trading Down 0.6%

DOC opened at $20.00 on Wednesday. The company’s 50 day moving average price is $19.68 and its two-hundred day moving average price is $19.26. The firm has a market capitalization of $13.79 billion, a price-to-earnings ratio of 11.06, a PEG ratio of 2.48 and a beta of 1.01. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.29 and a quick ratio of 1.29.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41). The business had revenue of $820.89 million during the quarter, compared to the consensus estimate of $739.18 million. Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The business’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be paid a $0.1017 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.22 annualized dividend and a yield of 6.1%. Healthpeak Properties’s dividend payout ratio (DPR) is 225.93%.

Insider Activity at Healthpeak Properties

In other news, EVP Ankit Patadia sold 6,115 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $20.78, for a total value of $127,069.70. Following the transaction, the executive vice president owned 2,838 shares in the company, valued at $58,973.64. The trade was a 68.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of DOC. Pension & Wealth Management Advisors Inc. bought a new stake in Healthpeak Properties in the third quarter worth about $27,000. Clearstead Trust LLC boosted its stake in Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 543 shares during the last quarter. Security National Bank of SO Dak bought a new position in shares of Healthpeak Properties during the 2nd quarter valued at approximately $32,000. Avalon Trust Co bought a new position in shares of Healthpeak Properties during the 1st quarter valued at approximately $34,000. Finally, Latitude Advisors LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $34,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.